Metraipolis › archive › dc_7adabd32e236
Abacavir/dolutegravir/lamivudine — Wikipedia (en)
- Source
- Wikipedia (en)
- Original
- https://en.wikipedia.org/wiki/Abacavir/dolutegravir/lamivudine
- License (as archived)
- CC-BY-SA-4.0
- Archived
- 2026-11-07T05:17:30.460Z
- SHA-256 of the archived text
d2fe67e4d01d1d189023a967896511efde01cb98c50819c56a32fa20a9be947b- Stable URL of this page
https://metraipolis.com/documento/dc_7adabd32e236
How to cite
Abacavir/dolutegravir/lamivudine — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/Abacavir/dolutegravir/lamivudine (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_7adabd32e236 (Metraipolis archive dc_7adabd32e236, sha256 d2fe67e4d01d1d189023a967896511efde01cb98c50819c56a32fa20a9be947b)
BibTeX
@misc{dc7adabd32e236,
title = {Abacavir/dolutegravir/lamivudine — Wikipedia (en)},
howpublished = {Wikipedia (en)},
url = {https://en.wikipedia.org/wiki/Abacavir/dolutegravir/lamivudine},
note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_7adabd32e236; sha256 d2fe67e4d01d1d189023a967896511efde01cb98c50819c56a32fa20a9be947b},
year = {2026}
}Archived text
Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/Abacavir/dolutegravir/lamivudine. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Abacavir/dolutegravir/lamivudine, sold under the brand name Triumeq among others, is a fixed-dose combination antiretroviral medication for the treatment of HIV/AIDS. It is a combination of three medications with different and complementary mechanisms of action: abacavir (reverse transcriptase inhibitor), dolutegravir (integrase inhibitor) and lamivudine (nucleoside analog reverse transcriptase inhibitor). Abacavir is a nucleotide reverse transcriptase inhibitor. Specifically, abacavir is a guanosine analogue that interferes with HIV viral RNA-dependent DNA polymerase, ultimately resulting in inhibition of replication of HIV. Dolutegravir inhibits the HIV replication cycle by binding to the integrase active site and inhibiting the strand transfer step of HIV-1 DNA integration. Lamivudine is a cytosine analogue that inhibits HIV reverse transcription by terminating the viral DNA chain. The medication was developed by ViiV Healthcare and was approved for use in the United States and in the European Union in 2014. The combination is on the World Health Organization's List of Essential Medicines. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (deposito sistematico; retro-catalogo: tutte le voci di Wikipedia in inglese, in ordine alfabetico). Fonte: Wikipedia in inglese, voce «Abacavir/dolutegravir/lamivudine» — https://en.wikipedia.org/wiki/Abacavir/dolutegravir/lamivudine Wikidata Q18208897: «drug combination for HIV» (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q18208897 Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/Abacavir/dolutegravir/lamivudine?action=history). Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza. Estratto dell'introduzione non modificato nel contenuto; revisione 1335492762, consultata il 2026-11-07T05:14:49.941Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: d9efade86b51aa22c04d882def5e2281b52c76dc9fa595b306f5e665d534ff5e